SPEXOTRAS 0.05 mg/ml, powder for oral solution bottle
Active ingredients: Trametinib dimethyl sulfoxide, Trametinib
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral solutionbottleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPEXOTRAS 0,05 mg/mL, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) avec fermeture de sécurité enfant de 4,7 mg avec adaptateur(s) pour flacon avec seringue(s) pour administration orale
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64421282CIP73028415CIP133400930284155Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRAMÉTINIBpoudre | 4,7 mg · un flacon | FT |
| DIMETHYLSUFLOXYDE DE TRAMÉTINIBpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.